GIF warns – in April 2019, more known drugs were removed from the market! In April 2019, the Chief Pharmaceutical Inspectorate announced three decisions to withdraw other popular medicines from the market. These included painkillers and antidepressants and popular drugs for constipation.
GIF draws the medicine back!
The Chief Pharmaceutical Inspectorate in April informed the withdrawal of further medicines from the market. Within a month GIF has issued new warnings about the distribution of popular prescription drugs. Drugs withdrawn from the market were analgesics and antidepressants and popular drugs for constipation.
GIF decisions about drugs, and in a specific drug series in principle, they are valid throughout the country. All GIF warnings were given for withdrawal of medicines from the market it can be enforced immediately.
New GIF alerts: more medications have been taken back
The Chief Pharmaceutical Inspectorate receives information, usually from responsible entities, about withdrawing from the market and preventing a series of drugs in circulation. In April 2019, GIF announced three warnings about the removal of popular prescription drugs from the market.
What medications have you taken back? What series of drugs have you pulled out of the market? Full information and including alerts can be found on the Chief Pharmaceutical Inspectorate's website – HERE
Medicines withdrawn – April 2019
In April 2019, GIF announced new warnings about the withdrawal of medicines from the market.
- NuTRIflex Lipid special
- Spasmoline 60 mg
- Andepin 20 mg
- Kalium is sugar free effliescens
Medicines withdrawn – April 2019 – detailed information:
[*]NuTRIflex Lipid – special responsible entity B. Braun Melsungen AG – more info CLICK HERE
[*]ENEMA – responsible entity Laboratorium Galenowe Olsztyn Sp. z o.o. – more information CLICK HERE
[*]Spasmoline 60 mg – the entity responsible Przedsiębiorstwo Farmaceutyczno-Chemiczne SYNTEZA Sp. z o.o. – more information CLICK HERE
[*]Andepin 20 mg – responsible entity Przedsiębiorstwo Farmaceutyczno-Chemiczne SYNTEZA Sp. z o.o. – more information CLICK HERE
[*]Kalium effervescens bezcukrowy – responsible entity Przedsiębiorstwo Farmaceutyczno-Chemiczne SYNTEZA Sp. z o.o. – more information CLICK HERE
Check whether you have withdrawn medicines at home!
Your medicines have been pulled out of the market. What to do?
If you have found the one you are on the list of medicines that have been withdrawn, compare its batch number with the batch number on the list. You will find it on the package. If your medication belongs to the expired series, return it to the pharmacy. You can ask your doctor for a prescription for a safe replacement for your medication.
What else can you do? Look at the following gallery:
In addition to the notice removed, GIF also announced a ban on placing on the market the following medicinal products: t
- Andepin 20 mg hard capsules;
- Folicid 15 mg tablets;
- Folacid 5 mg tablets;
- Kalium efiervescens sugar-free 782 mg of potassium ions / 3 g, erosive particles; 60 mg spasmoline hard capsules;
- Tramadol synthesis 50 mg hard capsules;
- Tramadol Synthesis 100 mg / 1 ml oral drops;
- Vitamin A + E Synthesis of soft capsules 30,000 IU + 70 mg.
Responsible entity: Przedsiębiorstwo Farmaceutyczno-Chemiczne SYNTEZA Sp. o 0.0.
The decision could be enforced immediately.
The controls on 16-18 days show that Przedsiębiorstwo Farmaceutyczno-Chemiczne SYNTEZA Sp. z not all legal requirements for the production of medicines have been met. GIF inspectors found, inter alia, repeated complaints about one of the withdrawn Spasmoliny series, where the end date of the drug was printed with an error.
At the same time, it was emphasized that "withdrawn products did not threaten the health and life of patients in any way".
Drugs withdrawn from the market – GIF warns
The series of suspended drugs in Poland can be reintroduced to the market after evidence on the safety of its use has been presented. If the drug is withdrawn – there is no possibility of resetting the medicine on the market.